These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 2561214
1. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions. Tsai BS, Villani-Price D, Keith RH, Zemaitis JM, Bauer RF, Leonard R, Djuric SW, Shone RL. Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214 [Abstract] [Full Text] [Related]
2. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils. Tsai BS, Keith RH, Villani-Price D, Haack RA, Djuric SW. J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959 [Abstract] [Full Text] [Related]
3. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT. J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083 [Abstract] [Full Text] [Related]
4. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. Kew RR, Grimaldi CM, Furie MB, Fleit HB. J Immunol; 1992 Aug 01; 149(3):989-97. PubMed ID: 1321856 [Abstract] [Full Text] [Related]
13. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4. Kurrasch R, Elfman F, Perez HD. J Immunol; 1989 Sep 15; 143(6):1969-73. PubMed ID: 2550548 [Abstract] [Full Text] [Related]
14. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. Harvath L, McCall CE, Bass DA, McPhail LC. J Immunol; 1987 Nov 01; 139(9):3055-61. PubMed ID: 2822802 [Abstract] [Full Text] [Related]
15. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist. Marder P, Sawyer JS, Froelich LL, Mann LL, Spaethe SM. Biochem Pharmacol; 1995 May 26; 49(11):1683-90. PubMed ID: 7786309 [Abstract] [Full Text] [Related]
16. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events. Fretland DJ, Anglin CP, Bremer M, Isakson P, Widomski DL, Paulson SK, Docter SH, Djuric SW, Penning TD, Yu S. Inflammation; 1995 Apr 26; 19(2):193-205. PubMed ID: 7601505 [Abstract] [Full Text] [Related]
17. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function. Barnette MS, Rush J, Marshall LA, Foley JJ, Schmidt DB, Sarau HM. Biochem Pharmacol; 1994 Apr 29; 47(9):1661-7. PubMed ID: 8185681 [Abstract] [Full Text] [Related]
18. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils. Patrick RA, Peters PA, Issekutz AC. Agents Actions; 1993 Nov 29; 40(3-4):186-90. PubMed ID: 8023742 [Abstract] [Full Text] [Related]
19. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment. Fletcher MP. J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618 [Abstract] [Full Text] [Related]
20. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178. Ohmi N, Tani C, Yamada K, Fukui M. Inflammation; 1994 Apr 01; 18(2):129-40. PubMed ID: 8070898 [Abstract] [Full Text] [Related] Page: [Next] [New Search]